Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
JCI Insight ; 9(5)2024 Mar 08.
Artículo en Inglés | MEDLINE | ID: mdl-38271085

RESUMEN

High-grade serous carcinoma (HGSC) is the most lethal gynecological malignancy in the United States. Late diagnosis and the emergence of chemoresistance have prompted studies into how the tumor microenvironment, and more recently tumor innervation, may be leveraged for HGSC prevention and interception. In addition to stess-induced sources, concentrations of the sympathetic neurotransmitter norepinephrine (NE) in the ovary increase during ovulation and after menopause. Importantly, NE exacerbates advanced HGSC progression. However, little is known about the role of NE in early disease pathogenesis. Here, we investigated the role of NE in instigating anchorage independence and micrometastasis of preneoplastic lesions from the fallopian tube epithelium (FTE) to the ovary, an essential step in HGSC onset. We found that in the presence of NE, FTE cell lines were able to survive in ultra-low-attachment (ULA) culture in a ß-adrenergic receptor-dependent (ß-AR-dependent) manner. Importantly, spheroid formation and cell viability conferred by treatment with physiological sources of NE were abrogated using the ß-AR blocker propranolol. We have also identified that NE-mediated anoikis resistance may be attributable to downregulation of colony-stimulating factor 2. These findings provide mechanistic insight and identify targets that may be regulated by ovary-derived NE in early HGSC.


Asunto(s)
Cistadenocarcinoma Seroso , Neoplasias Ováricas , Femenino , Humanos , Neoplasias Ováricas/metabolismo , Cistadenocarcinoma Seroso/tratamiento farmacológico , Cistadenocarcinoma Seroso/metabolismo , Cistadenocarcinoma Seroso/patología , Trompas Uterinas/metabolismo , Trompas Uterinas/patología , Anoicis , Norepinefrina/farmacología , Norepinefrina/metabolismo , Microambiente Tumoral
2.
JCI Insight ; 8(12)2023 06 22.
Artículo en Inglés | MEDLINE | ID: mdl-37345659

RESUMEN

Epigenetic aberrations, including posttranslational modifications of core histones, are major contributors to cancer. Here, we define the status of histone H2B monoubiquitylation (H2Bub1) in clear cell ovarian carcinoma (CCOC), low-grade serous carcinoma, and endometrioid carcinomas. We report that clear cell carcinomas exhibited profound loss, with nearly all cases showing low or negative H2Bub1 expression. Moreover, we found that H2Bub1 loss occurred in endometriosis and atypical endometriosis, which are established precursors to CCOCs. To examine whether dysregulation of a specific E3 ligase contributes to the loss of H2Bub1, we explored expression of ring finger protein 40 (RNF40), ARID1A, and UBR7 in the same case cohort. Loss of RNF40 was significantly and profoundly correlated with loss of H2Bub1. Using genome-wide DNA methylation profiles of 230 patients with CCOC, we identified hypermethylation of RNF40 in CCOC as a likely mechanism underlying the loss of H2Bub1. Finally, we demonstrated that H2Bub1 depletion promoted cell proliferation and clonogenicity in an endometriosis cell line. Collectively, our results indicate that H2Bub1 plays a tumor-suppressive role in CCOCs and that its loss contributes to disease progression.


Asunto(s)
Carcinoma , Endometriosis , Neoplasias Ováricas , Neoplasias Peritoneales , Femenino , Humanos , Endometriosis/genética , Histonas/genética , Neoplasias Ováricas/genética
3.
Sci Rep ; 13(1): 1537, 2023 01 27.
Artículo en Inglés | MEDLINE | ID: mdl-36707610

RESUMEN

Long interspersed element 1 (LINE-1) open reading frame 1 protein (ORF1p) expression is a common feature of many cancer types, including high-grade serous ovarian carcinoma (HGSOC). Here, we report that ORF1p is not only expressed but also released by ovarian cancer and primary tumor cells. Immuno-multiple reaction monitoring-mass spectrometry assays showed that released ORF1p is confidently detectable in conditioned media, ascites, and patients' plasma, implicating ORF1p as a potential biomarker. Interestingly, ORF1p expression is detectable in fallopian tube (FT) epithelial precursors of HGSOC but not in benign FT, suggesting that ORF1p expression in an early event in HGSOC development. Finally, treatment of FT cells with DNA methyltransferase inhibitors led to robust expression and release of ORF1p, validating the regulatory role of DNA methylation in LINE-1 repression in non-tumorigenic tissue.


Asunto(s)
Neoplasias Ováricas , Femenino , Humanos , Biomarcadores/metabolismo , Trompas Uterinas/metabolismo , Neoplasias Ováricas/patología , Proteínas/metabolismo , Elementos de Nucleótido Esparcido Largo
4.
Sci Signal ; 15(728): eabm2496, 2022 04 05.
Artículo en Inglés | MEDLINE | ID: mdl-35380877

RESUMEN

PAX8 is a master transcription factor that is essential during embryogenesis and promotes neoplastic growth. It is expressed by the secretory cells lining the female reproductive tract, and its deletion during development results in atresia of reproductive tract organs. Nearly all ovarian carcinomas express PAX8, and its knockdown results in apoptosis of ovarian cancer cells. To explore the role of PAX8 in these tissues, we purified the PAX8 protein complex from nonmalignant fallopian tube cells and high-grade serous ovarian carcinoma cell lines. We found that PAX8 was a member of a large chromatin remodeling complex and preferentially interacted with SOX17, another developmental transcription factor. Depleting either PAX8 or SOX17 from cancer cells altered the expression of factors involved in angiogenesis and functionally disrupted tubule and capillary formation in cell culture and mouse models. PAX8 and SOX17 in ovarian cancer cells promoted the secretion of angiogenic factors by suppressing the expression of SERPINE1, which encodes a proteinase inhibitor with antiangiogenic effects. The findings reveal a non-cell-autonomous function of these transcription factors in regulating angiogenesis in ovarian cancer.


Asunto(s)
Neoplasias Ováricas , Factor de Transcripción PAX8 , Factores de Transcripción SOXF , Factores de Transcripción , Animales , Trompas Uterinas/metabolismo , Trompas Uterinas/patología , Femenino , Proteínas HMGB/genética , Proteínas HMGB/metabolismo , Humanos , Ratones , Clasificación del Tumor , Neoplasias Ováricas/metabolismo , Factor de Transcripción PAX8/genética , Factor de Transcripción PAX8/metabolismo , Factores de Transcripción SOXF/genética , Factores de Transcripción SOXF/metabolismo , Factores de Transcripción/metabolismo
5.
Cells ; 10(12)2021 12 10.
Artículo en Inglés | MEDLINE | ID: mdl-34944001

RESUMEN

Dense tumor innervation is associated with enhanced cancer progression and poor prognosis. We observed innervation in breast, prostate, pancreatic, lung, liver, ovarian, and colon cancers. Defining innervation in high-grade serous ovarian carcinoma (HGSOC) was a focus since sensory innervation was observed whereas the normal tissue contains predominantly sympathetic input. The origin, specific nerve type, and the mechanisms promoting innervation and driving nerve-cancer cell communications in ovarian cancer remain largely unknown. The technique of neuro-tracing enhances the study of tumor innervation by offering a means for identification and mapping of nerve sources that may directly and indirectly affect the tumor microenvironment. Here, we establish a murine model of HGSOC and utilize image-guided microinjections of retrograde neuro-tracer to label tumor-infiltrating peripheral neurons, mapping their source and circuitry. We show that regional sensory neurons innervate HGSOC tumors. Interestingly, the axons within the tumor trace back to local dorsal root ganglia as well as jugular-nodose ganglia. Further manipulations of these tumor projecting neurons may define the neuronal contributions in tumor growth, invasion, metastasis, and responses to therapeutics.


Asunto(s)
Cistadenocarcinoma Seroso/patología , Tejido Nervioso/patología , Neoplasias Ováricas/patología , Animales , Cistadenocarcinoma Seroso/diagnóstico por imagen , Modelos Animales de Enfermedad , Femenino , Ganglios Espinales/metabolismo , Ratones Endogámicos C57BL , Tejido Nervioso/diagnóstico por imagen , Neoplasias Ováricas/diagnóstico por imagen , Fosfohidrolasa PTEN/metabolismo , Células Receptoras Sensoriales/patología , Proteína p53 Supresora de Tumor/metabolismo , Ultrasonografía
6.
Nat Med ; 25(10): 1505-1511, 2019 10.
Artículo en Inglés | MEDLINE | ID: mdl-31591596

RESUMEN

The essential product of the Duchenne muscular dystrophy (DMD) gene is dystrophin1, a rod-like protein2 that protects striated myocytes from contraction-induced injury3,4. Dystrophin-related protein (or utrophin) retains most of the structural and protein binding elements of dystrophin5. Importantly, normal thymic expression in DMD patients6 should protect utrophin by central immunologic tolerance. We designed a codon-optimized, synthetic transgene encoding a miniaturized utrophin (µUtro), deliverable by adeno-associated virus (AAV) vectors. Here, we show that µUtro is a highly functional, non-immunogenic substitute for dystrophin, preventing the most deleterious histological and physiological aspects of muscular dystrophy in small and large animal models. Following systemic administration of an AAV-µUtro to neonatal dystrophin-deficient mdx mice, histological and biochemical markers of myonecrosis and regeneration are completely suppressed throughout growth to adult weight. In the dystrophin-deficient golden retriever model, µUtro non-toxically prevented myonecrosis, even in the most powerful muscles. In a stringent test of immunogenicity, focal expression of µUtro in the deletional-null German shorthaired pointer model produced no evidence of cell-mediated immunity, in contrast to the robust T cell response against similarly constructed µDystrophin (µDystro). These findings support a model in which utrophin-derived therapies might be used to treat clinical dystrophin deficiency, with a favorable immunologic profile and preserved function in the face of extreme miniaturization.


Asunto(s)
Terapia Genética , Distrofias Musculares/terapia , Distrofia Muscular Animal/terapia , Distrofia Muscular de Duchenne/terapia , Utrofina/genética , Animales , Dependovirus/genética , Modelos Animales de Enfermedad , Perros , Distrofina/genética , Humanos , Ratones , Ratones Endogámicos mdx , Contracción Muscular/genética , Músculo Esquelético/metabolismo , Músculo Esquelético/patología , Distrofias Musculares/genética , Distrofias Musculares/patología , Distrofia Muscular Animal/genética , Distrofia Muscular Animal/patología , Distrofia Muscular de Duchenne/genética , Distrofia Muscular de Duchenne/patología , Transgenes/genética , Utrofina/uso terapéutico
7.
Med Mycol ; 57(6): 688-693, 2019 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-30462288

RESUMEN

Coccidioidomycosis, the fungal infection caused by dimorphic Coccidioides species, is typically diagnosed by histopathologic identification of spherules, by culture, or by serology. These tests are reliable but time-intensive, delaying diagnosis and treatment. Rapid real-time polymerase chain reaction (RT-PCR) can be performed and was validated to identify Coccidioides immitis using an in-house developed assay for the Becton Dickinson molecular instrument (BD MAXTM). These studies were performed using patient samples that had been shown to be positive on previously set up fungal cultures. To evaluate this new RT-PCR test in the clinical setting, we conducted a retrospective chart review of patients (N = 1160) who underwent Coccidioides PCR (Cocci PCR) on clinical samples between March 1, 2014, and Dec 31, 2016. We abstracted clinical, microbiologic, serologic, radiographic, treatment, and follow-up data. Specimens of cerebrospinal fluid (CSF), bronchioalveolar lavage fluid (BAL), lung tissue biopsy (LTB), sputum, and pleural fluid were evaluated to determine sensitivity and specificity. Of the 113 specimens that tested positive for Cocci PCR, all had clinical disease defined by traditional clinical criteria, yielding 100% specificity. Overall sensitivity was 74% versus 46% for fungal culture and was available in 4 hours rather than 1-2 weeks. Sensitivities varied by source material and clinical setting. CSF had a sensitivity of 59%, BAL for acute pneumonia 91%, sputum for acute pneumonia 94%, pleural fluid 86%, but LTB for lung nodules only 44%. Overall positive predictive value (PPV) was 100%, while negative predictive value (NPV) was 96%, but again this varied by specimen and clinical setting. Our experience with clinical testing of >1160 specimens over 2-3 years shows we can utilize this technology to improve our ability to diagnose disease but that the sensitivity varies by specimen source and clinical setting.


Asunto(s)
Coccidioides/aislamiento & purificación , Coccidioidomicosis/diagnóstico , Reacción en Cadena en Tiempo Real de la Polimerasa , Biopsia , Líquido del Lavado Bronquioalveolar/microbiología , California , Coccidioidomicosis/sangre , Humanos , Pulmón/microbiología , Pulmón/patología , Derrame Pleural/microbiología , Valor Predictivo de las Pruebas , Sensibilidad y Especificidad , Esputo/microbiología
11.
Mycology ; 7(3): 99-101, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-30123621

RESUMEN

Coccidioidomycosis causes substantial morbidity in endemic areas. Disseminated coccidioidomycosis is an AIDS defining condition and treatment often requires lifelong antifungal therapy. Sertraline, a widely used serotonin-reuptake inhibitor anti-depressant, has demonstrated activity against Candida and Cryptococcus sp. both in vitro and in vivo. To evaluate if sertraline has activity against Coccidioides, the minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of sertraline for four clinical isolates of C. immitis were determined. Sertraline was observed to have an MIC range of 4-8 µg/ml and MFC also of 4-8 µg/ml for Coccidioides. These MIC and MFC results for C. immitis are similar to those reported for Cryptococcus sp. suggesting sertraline may potentially have utility for the treatment of coccidioidomycosis.

12.
J Clin Microbiol ; 53(3): 926-9, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25588654

RESUMEN

Rapid real-time PCR (RT-PCR) can be performed in a community hospital setting to identify Coccidioides species using the new Becton Dickinson molecular instrument BD Max. Following sample preparation, DNA extraction and PCR were performed on the BD Max using the BD Max extraction kit ExK-DNA-1 test strip and a master mix prepared by BioGX (Birmingham, AL). Sample preparation took 2 h, and testing on the BD Max took an additional 2 h. Method sensitivity and specificity were evaluated along with the limits of detection to confirm that this convenient method would provide medically useful information. Using serial dilutions, the lower limit of detection was determined to be 1 CFU/µl. Testing with this method was validated using samples from various body sites, including bronchial alveolar lavage (BAL) fluid; sputum and lung tissue samples; and pleural and spinal fluids. Safety protocols were established, and specimen preparation processes were developed for the various types of specimens. The range for the cycle threshold (CT) indicating adequate fluorescent signal to signify a positive result was established along with the acceptable range for the internal standard. Positive controls run with each batch were prepared by spiking a pooled BAL fluid specimen with a known dilution of Coccidioides immitis organism. Our experience with testing >330 patient samples shows that clinically relevant information can be available within 4 h using an RT-PCR method on the BD Max to identify Coccidioides spp., with sensitivity equivalent to culture.


Asunto(s)
Coccidioides/aislamiento & purificación , Coccidioidomicosis/diagnóstico , Técnicas de Diagnóstico Molecular/métodos , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Líquidos Corporales/microbiología , Coccidioides/genética , Humanos , Sensibilidad y Especificidad , Factores de Tiempo
15.
Nurs Ethics ; 19(2): 245-51, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22140183

RESUMEN

Advance Directives are under-utilized, both from the fact that few Americans have them and that health professionals don't always rely on Advance Directives provided by patients. Many health professionals have philosophical objections to their use. Using a fictitious case as background, five different objections to the use of Advance Directives will be discussed and arguments against those objections will be posed along with suggestions to improve Advance Directives.


Asunto(s)
Directivas Anticipadas/ética , Disentimientos y Disputas , Ética en Enfermería , Voluntad en Vida , Directivas Anticipadas/legislación & jurisprudencia , Estado de Conciencia , Continuidad de la Atención al Paciente/ética , Enfermedad Crítica/enfermería , Enfermedad Crítica/terapia , Empatía/ética , Humanos , Consentimiento Informado/ética , Control Interno-Externo , Acontecimientos que Cambian la Vida , Voluntad en Vida/ética , Competencia Mental , Relaciones Enfermero-Paciente/ética , Defensa del Paciente , Personeidad , Teoría Psicológica , Autoimagen , Factores de Tiempo , Estados Unidos
16.
Circulation ; 112(12): 1780-8, 2005 Sep 20.
Artículo en Inglés | MEDLINE | ID: mdl-16157771

RESUMEN

BACKGROUND: The muscular dystrophies exemplify a class of systemic disorders for which widespread protein replacement in situ is essential for treatment of the underlying genetic disorder. Somatic gene therapy will require efficient, scale-independent transport of DNA-containing macromolecular complexes too large to cross the continuous endothelia under physiological conditions. Previous studies in large-animal models have revealed a trade-off between the efficiency of gene transfer and the inherent safety of the required surgical and pharmacological interventions to achieve this. METHODS AND RESULTS: Rats and dogs underwent limb or hemibody isolation via atraumatic tourniquet placement or myocardial isolation via heterotopic transplantation. Recombinant adenovirus (10(13) particles per kilogram) or recombinant adeno-associated virus (10(14) genome copies/kg) encoding the lacZ transgene was delivered through pressurized venous infusion without pharmacological mediators. Muscle exhibited almost 100% myofiber transduction in rats and dogs by X-galactosidase staining and significantly higher beta-galactosidase levels compared with nonpressurized delivery. No significant difference was seen in beta-galactosidase levels between 100- or 400-mm Hg groups. The <50-mm Hg group yielded inhomogeneous and significantly lower transgene expression. CONCLUSIONS: Uniform scale- and vector-independent skeletal and cardiac myofiber transduction is facilitated by pressurized venous infusion in anatomic domains isolated from the central circulation without pharmacological interference with cardiovascular homeostasis. We provide the first demonstration of uniform gene transfer to muscle fibers of an entire extremity in the dog, providing a firm foundation for further translational studies of efficacy in canine models for human diseases.


Asunto(s)
Dependovirus/genética , Músculo Esquelético/fisiología , Animales , Perros , Técnicas de Transferencia de Gen , Vectores Genéticos , Corazón , Trasplante de Corazón/fisiología , Masculino , Ratas , Ratas Sprague-Dawley , beta-Galactosidasa/genética
17.
Nature ; 428(6981): 415-8, 2004 Mar 25.
Artículo en Inglés | MEDLINE | ID: mdl-15042088

RESUMEN

Powerful masticatory muscles are found in most primates, including chimpanzees and gorillas, and were part of a prominent adaptation of Australopithecus and Paranthropus, extinct genera of the family Hominidae. In contrast, masticatory muscles are considerably smaller in both modern and fossil members of Homo. The evolving hominid masticatory apparatus--traceable to a Late Miocene, chimpanzee-like morphology--shifted towards a pattern of gracilization nearly simultaneously with accelerated encephalization in early Homo. Here, we show that the gene encoding the predominant myosin heavy chain (MYH) expressed in these muscles was inactivated by a frameshifting mutation after the lineages leading to humans and chimpanzees diverged. Loss of this protein isoform is associated with marked size reductions in individual muscle fibres and entire masticatory muscles. Using the coding sequence for the myosin rod domains as a molecular clock, we estimate that this mutation appeared approximately 2.4 million years ago, predating the appearance of modern human body size and emigration of Homo from Africa. This represents the first proteomic distinction between humans and chimpanzees that can be correlated with a traceable anatomic imprint in the fossil record.


Asunto(s)
Evolución Molecular , Fósiles , Mutación del Sistema de Lectura/genética , Hominidae/anatomía & histología , Hominidae/genética , Cadenas Pesadas de Miosina/genética , Miosinas/genética , Filogenia , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Biología Computacional , Perros , Exones/genética , Historia Antigua , Humanos , Macaca/anatomía & histología , Macaca/genética , Músculos Masticadores/anatomía & histología , Datos de Secuencia Molecular , Cadenas Pesadas de Miosina/química , Miosinas/química , Pan troglodytes/anatomía & histología , Pan troglodytes/genética , Pongo pygmaeus/anatomía & histología , Pongo pygmaeus/genética , Cráneo/anatomía & histología , Factores de Tiempo
18.
J Biol Chem ; 277(31): 27593-605, 2002 Aug 02.
Artículo en Inglés | MEDLINE | ID: mdl-11971910

RESUMEN

The mammalian skeletal myosin heavy chain locus is composed of a six-membered family of tandemly linked genes whose complex regulation plays a central role in striated muscle development and diversification. We have used publicly available genomic DNA sequences to provide a theoretical foundation for an experimental analysis of transcriptional regulation among the six promoters at this locus. After reconstruction of annotated drafts of the human and murine loci from fragmented DNA sequences, phylogenetic footprint analysis of each of the six promoters using standard and Bayesian alignment algorithms revealed unexpected patterns of DNA sequence conservation among orthologous and paralogous gene pairs. The conserved domains within 2.0 kilobases of each transcriptional start site are rich in putative muscle-specific transcription factor binding sites. Experiments based on plasmid transfection in vitro and electroporation in vivo validated several predictions of the bioinformatic analysis, yielding a picture of synergistic interaction between proximal and distal promoter elements in controlling developmental stage-specific gene activation. Of particular interest for future studies of heterologous gene expression is a 650-base pair construct containing modules from the proximal and distal human embryonic myosin heavy chain promoter that drives extraordinarily powerful transcription during muscle differentiation in vitro.


Asunto(s)
Familia de Multigenes , Músculo Esquelético/fisiología , Cadenas Pesadas de Miosina/genética , Animales , Secuencia de Bases , Secuencia Conservada , ADN/química , ADN/genética , Cartilla de ADN , Electroporación , Regulación del Desarrollo de la Expresión Génica , Humanos , Ratones , Datos de Secuencia Molecular , Músculo Esquelético/embriología , Filogenia , Regiones Promotoras Genéticas , Alineación de Secuencia , Homología de Secuencia de Ácido Nucleico , Activación Transcripcional
19.
Phys Sportsmed ; 8(12): 40-48, 1980 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29251214

RESUMEN

Snow shovelers often complain about muscular aches and pains, but the demands on their metabolic and cardiovascular systems may be more significant.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA